Abstract 1896: Patient-derived HER3 mutations transform ER+ and HER2+ breast cancer cells via MAPK pathway activation.

Rosalin Mishra,Samar Alanazi,Long Yuan,Thomas Solomon,Tarjani M. Thaker,Natalia Jura,Joan T. Garrett

Abstract B101: Engineered PD-1 variants as immunotherapies for cancer.

Sydney R. Gordon,Roy Maute,Aaron Mayer,Melissa McCracken,Arutselvan Natarajan,Nan Guo,Richard Kimura,Jonathan M. Tsai,Aashish Manglik,Andrew Kruse,Sanjiv Gambhir,Irving L. Weissman,Aaron M. Ring

Structural Features of the Kinase Domain.

Dániel Süveges,Natalia Jura

Untitled Publication

Shimba, N. Nomura, A.M., Marnett, A.B. and Craik, C.S. Herpesvirus Protease Inhibition by Dimer Disruption. J. Virol

Untitled Publication

Brachyurins. Tsu, C., and Craik, C.S. Handbook of Proteolytic Enzymes

Untitled Publication

T.T. Baird Jr., B. Wang, M. Lodder, S.M. Hecht and C.S. Craik. Generation of Active Trypsin by Chemical Cleavage. Tetrahedron Letters

Untitled Publication

K.K. Reiling, T.R. Pray, C.S. Craik, R.M. Stroud. Structure: Regulation of Activity and Dimerization by Conserved Structural Elements. Biochemistry

Untitled Publication

C.S. Craik & R.J. Fletterick. The Marriage of Protein Structure and Pharmaceutical Discovery. Biotech. & Appl. Biochem. 26

Untitled Publication

Z. Yu, P. Caldera, F. McPhee, J. DeVoss, P.R. Jones, A. Burlingame, I. Kuntz, C.S. Craik & P.R. Ortiz de Montellano. Irreversible Inhibition of the HIV-1 Protease: Targeting Alkylating Agents to the Catalytic Aspartate Groups. J. Amer. Chem. Soc. 118

Untitled Publication

W.S. Willett, L.S. Brinen, R.J. Fletterick & C.S. Craik. Delocalizing Trypsin Specificity with Metal-Activation. Biochem; 35

Pages